Taken together, those above results showed that, compared with normal cells, CDC20 was particularly overexpressed in CRC and was upregulated after radiation, highlighting its potential as a novel therapeutic target for advanced CRC. This evidence concerns the gene CDC20 and colorectal carcinoma.